Soluble Klotho is associated with mortality and cardiovascular events in hemodialysis
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Soluble Klotho is associated with mortality and cardiovascular events in hemodialysis
Authors
Keywords
Klotho, Hemodialysis, Arteriosclerosis, Cardiovascular events, Mortality
Journal
BMC Nephrology
Volume 20, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-06-11
DOI
10.1186/s12882-019-1391-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Circulating Klotho levels can predict long-term macrovascular outcomes in type 2 diabetic patients
- (2018) Heng-Chih Pan et al. ATHEROSCLEROSIS
- Ambulatory Pulse Wave Velocity Is a Stronger Predictor of Cardiovascular Events and All-Cause Mortality Than Office and Ambulatory Blood Pressure in Hemodialysis PatientsNovelty and Significance
- (2017) Pantelis A. Sarafidis et al. HYPERTENSION
- Circulating Klotho Associates With Cardiovascular Morbidity and Mortality During Hemodialysis
- (2017) Christophe Marçais et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Recombinant α-Klotho may be prophylactic and therapeutic for acute to chronic kidney disease progression and uremic cardiomyopathy
- (2017) Ming Chang Hu et al. KIDNEY INTERNATIONAL
- Serum Phosphorus and Progression of CKD and Mortality: A Meta-analysis of Cohort Studies
- (2015) Jingjing Da et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Adverse Effects of Conventional Thrice-Weekly Hemodialysis: Is It Time to Avoid 3-Day Interdialytic Intervals?
- (2015) Panagiotis I. Georgianos et al. AMERICAN JOURNAL OF NEPHROLOGY
- Soluble klotho and mortality: The Ludwigshafen Risk and Cardiovascular Health Study
- (2015) Vincent M. Brandenburg et al. ATHEROSCLEROSIS
- Arterial Stiffness: A Novel Cardiovascular Risk Factor in Kidney Disease Patients
- (2015) Panagiotis Georgianos et al. Current Vascular Pharmacology
- Association between Serum Soluble Klotho Levels and Mortality in Chronic Hemodialysis Patients
- (2015) Naoko Otani-Takei et al. International Journal of Endocrinology
- Evaluation of a Novel Brachial Cuff-Based Oscillometric Method for Estimating Central Systolic Pressure in Hemodialysis Patients
- (2014) Pantelis A. Sarafidis et al. AMERICAN JOURNAL OF NEPHROLOGY
- Associations of FGF-23 and sKlotho with Cardiovascular Outcomes among Patients with CKD Stages 2-4
- (2014) S. Seiler et al. Clinical Journal of the American Society of Nephrology
- Soluble Klotho Protects against Uremic Cardiomyopathy Independently of Fibroblast Growth Factor 23 and Phosphate
- (2014) J. Xie et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Direct, Acute Effects of Klotho and FGF23 on Vascular Smooth Muscle and Endothelium
- (2014) Isabelle Six et al. PLoS One
- Prognostic Value and Link to Atrial Fibrillation of Soluble Klotho and FGF23 in Hemodialysis Patients
- (2014) Albina Nowak et al. PLoS One
- Fibroblast Growth Factor‐23 and Incident Coronary Heart Disease, Heart Failure, and Cardiovascular Mortality: The Atherosclerosis Risk In Communities Study
- (2014) Pamela L. Lutsey et al. Journal of the American Heart Association
- Circulating α-Klotho Levels in CKD and Relationship to Progression
- (2013) Hyoung Rae Kim et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- A Decreased Level of Serum Soluble Klotho Is an Independent Biomarker Associated with Arterial Stiffness in Patients with Chronic Kidney Disease
- (2013) Masashi Kitagawa et al. PLoS One
- Associations of fetuin-A and osteoprotegerin with arterial stiffness and early atherosclerosis in chronic hemodialysis patients
- (2013) Panagiotis Pateinakis et al. BMC Nephrology
- Suppression of Klotho expression by protein-bound uremic toxins is associated with increased DNA methyltransferase expression and DNA hypermethylation
- (2012) Chiao-Yin Sun et al. KIDNEY INTERNATIONAL
- Plasma Klotho is not related to kidney function and does not predict adverse outcome in patients with chronic kidney disease
- (2012) Sarah Seiler et al. KIDNEY INTERNATIONAL
- Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study
- (2012) Ivana Pavik et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Fibroblast growth factor 23 and soluble klotho in children with chronic kidney disease
- (2012) Mandy Wan et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Cardioprotection by Klotho through downregulation of TRPC6 channels in the mouse heart
- (2012) Jian Xie et al. Nature Communications
- FGF23 induces left ventricular hypertrophy
- (2011) Christian Faul et al. JOURNAL OF CLINICAL INVESTIGATION
- FGF-23 Associates with Death, Cardiovascular Events, and Initiation of Chronic Dialysis
- (2011) J. Kendrick et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Plasma Klotho and Mortality Risk in Older Community-Dwelling Adults
- (2011) R. D. Semba et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Klotho is associated with VEGF receptor-2 and the transient receptor potential canonical-1 Ca2+ channel to maintain endothelial integrity
- (2010) T. Kusaba et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease
- (2009) Orlando M. Gutiérrez et al. CIRCULATION
- Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis
- (2008) Orlando M. Gutiérrez et al. NEW ENGLAND JOURNAL OF MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started